by adminAdrianRamirez | Jan 20, 2015 | Axim Biotechnologies, Company News, Press Releases
Leading Industrial Hemp Biosciences Company Sets Sites on Furthering Ophthalmology-Focused Cannabinoid Research and Development, Expands R&D Portfolio With Cannabinoid-Based Ophthalmological Products NEW YORK, Jan. 20, 2015 (GLOBE NEWSWIRE) — AXIM...
by adminAdrianRamirez | Nov 20, 2014 | Axim Biotechnologies, Company News, Press Releases
Company’s Global Innovative Hemp-Based Products Manufacturing Facility Planned in Almere, The Netherlands NEW YORK, Nov. 20, 2014 (GLOBE NEWSWIRE) — AXIM Biotechnologies (OTC:AXIM) brings to market global innovative solutions that set the “green...
by adminAdrianRamirez | Nov 6, 2014 | Axim Biotechnologies, Company News, Press Releases
‘Invaluable Experience’ Set to Bolster Company’s Proposed Clinical Trials and Product Development NEW YORK, Nov. 6, 2014 (GLOBE NEWSWIRE) — AXIM Biotechnologies (OTC:AXIM) is setting the “green standard” in the industrial hemp...
by adminAdrianRamirez | Oct 30, 2014 | Axim Biotechnologies, Company News, Media Coverage
Company’s Proprietary Industrial Hemp Development, Production, and Delivery Methods Innovate Global Nutraceutical and Pharmaceutical Markets/em> NEW YORK, Oct. 30, 2014 (GLOBE NEWSWIRE) — AXIM Biotechnologies (OTC:AXIM) proudly announces its strategic...